Xiufen Chen Selected Research

Xiufen Chen Research Topics

Disease

13	Neoplasms (Cancer) 01/2023 - 05/2013
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 05/2013
4	Leukemia 01/2022 - 08/2013
4	Neoplasm Metastasis (Metastasis) 03/2018 - 04/2015
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 01/2023
2	Lymphoma (Lymphomas) 01/2024 - 01/2023
2	Heart Failure 01/2022 - 01/2021
2	Melanoma (Melanoma, Malignant) 01/2021 - 04/2015
2	Inflammation (Inflammations) 01/2019 - 11/2018
1	Hodgkin Disease (Hodgkin's Disease) 01/2024
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023
1	Squamous Cell Carcinoma of Head and Neck 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022
1	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2021
1	Obesity 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Atherosclerosis 12/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Reperfusion Injury 11/2018
1	Brain Ischemia (Cerebral Ischemia) 11/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Bites and Stings (Sting) 01/2016

Drug/Important Bio-Agent (IBA)

6	AntigensIBA 01/2022 - 05/2013
5	CytokinesIBA 01/2024 - 01/2016
5	Ursolic AcidIBA 03/2018 - 04/2015
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2015
2	Chimeric Antigen ReceptorsIBA 04/2024 - 12/2021
2	CalreticulinIBA 01/2020 - 01/2017
2	Matrix Metalloproteinases (MMPs)IBA 03/2018 - 07/2017
2	Silicon Dioxide (Silica)FDA LinkGeneric 07/2017 - 01/2017
2	Interferon Type IIBA 01/2017 - 01/2016
2	ProdrugsIBA 01/2017 - 04/2015
1	Bispecific AntibodiesIBA 01/2024
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2024
1	Tyrosine (L-Tyrosine)FDA Link 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	VaccinesIBA 01/2022
1	Cancer VaccinesIBA 01/2022
1	OvalbuminIBA 01/2022
1	Histocompatibility Antigens Class IIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 12/2021
1	Heme Oxygenase-1IBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 01/2021
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	Capsules (Microcapsules)IBA 01/2021
1	Nonprescription Drugs (Patent Medicines)IBA 01/2021
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2021
1	Natriuretic PeptidesIBA 01/2021
1	UbiquitinIBA 12/2019
1	Proteins (Proteins, Gene)FDA Link 12/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2019
1	Circular RNAIBA 01/2019
1	LuciferasesIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 11/2018
1	Neuroprotective AgentsIBA 11/2018
1	Toll-Like Receptor 4IBA 11/2018
1	ChitosanIBA 07/2017
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2017
1	AcidsIBA 03/2017
1	Ethylene Glycol (Monoethylene Glycol)IBA 03/2017
1	polyethylene glycol-poly(lactide-co-glycolide)IBA 03/2017
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 03/2017
1	1,6-diaminohexane (hexamethylenediamine)IBA 03/2017
1	MicellesIBA 03/2017
1	Drug CarriersIBA 01/2017
1	vadimezanIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	TriterpenesIBA 04/2015
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2015
1	Cell Adhesion MoleculesIBA 04/2015

Therapy/Procedure

6	Therapeutics 01/2024 - 03/2017
4	Immunotherapy 01/2024 - 01/2021
1	Injections 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Nanospheres 07/2017
1	Intravenous Administration 03/2017
1	Oral Administration 04/2015
1	Ligation 05/2013